Introduction
The lymphatic vasculature serves important physiological functions including the absorption of intestinal lipids, immune defense, and the return of tissue fluid and macromolecules to the blood vascular system (Witte et al., 2001) . It consists of a hierarchal network of initial and collecting lymphatic vessels which exhibit differences in physiological function, mural cell coverage, and gene expression (Karpanen and Mäkinen, 2006; Witte et al., 2006) . Initial lymphatic vessels absorb liquid and proteins that have leaked from blood capillaries, are free of mural cells, and highly express the lymphatic hyaluronan receptor LYVE-1 (Banerji et al., 1999; Witte et al., 2006) . Furthermore, they are comprised of a single layer of oak leaf-shaped endothelial cells with overlapping junctions (Földi et al., 2006) . In contrast, collecting lymphatic vessels exhibit intraluminal valves and actively transport lymph to central lymphatic-venous junctions through the coordinated contraction of overlying smooth muscle cells (Földi et al., 2006) . Moreover, collecting lymphatic vessels down-regulate the expression of LYVE-1 and are comprised of endothelial cells exhibiting an elongated morphology (Mäkinen et al., 2005; Baluk et al., 2007; Tammela et al., 2007) . These fundamental differences between initial and collecting lymphatic vessels are thought to arise in a step-wise fashion during embryonic and postnatal remodeling and maturation of the lymphatic vasculature (Oliver and Alitalo 2005) .
During development, the processes of lymphvasculogenesis and lymphangiogenesis produce a primary network of lymphatic vessels, which subsequently remodels into an ordered pattern of initial and collecting vessels. Sabin first described this remodeling process over 100 years ago in the skin of pig embryos (Sabin, 1904) . She demonstrated that a primary plexus of valveless lymphatic vessels first forms at the border between the dermis and subcutaneous tissue during embryonic development. Later, sprouts from the primary plexus invade the dermis and give rise to a secondary plexus of initial lymphatic vessels. During this time, vessels of the subcutaneous primary plexus develop valves and mature into collecting vessels (Sabin, 1904) . More recently, the same remodeling process was shown to occur postnatally in the skin of mice and to depend on reverse signaling by Developmental Biology 319 (2008) [309] [310] [311] [312] [313] [314] [315] [316] [317] [318] [319] [320] ephrinb2 (Mäkinen et al., 2005) . However, despite detailed descriptions of the remodeling of the lymphatic vasculature, the molecular mechanisms regulating this process have not been fully delineated.
In contrast, the molecular control of the remodeling of the blood vasculature has been extensively characterized and shown to depend on the Tie-2 ligand, Angiopoietin-2 (Ang-2; Maisonpierre et al., 1997; Gale et al., 2002; Hackett et al., 2002) . Ang2 −/− mice exhibit defects in the remodeling of the blood vasculature, but surprisingly, even more severe defects of the lymphatic system (Gale et al., 2002) . Ang2 −/− mice display chylous ascites, peripheral lymphedema and hypoplasia of the lymphatic vasculature (Gale et al., 2002) . Furthermore, mesenteric lymphatic vessels of Ang2 −/− mice are ragged and exhibit a poor association with smooth muscle cells whereas initial lymphatic vessels in the digestive organs are abnormally covered with SMCs (Gale et al., 2002; Shimoda et al., 2007) . Despite these detailed descriptions of Ang2 −/− mice, the precise nature of their lymphatic defects has yet to be elucidated. Here we show that Ang-2 is a crucial regulator of lymphatic remodeling by demonstrating that Ang2 −/− mice exhibit defects in postnatal remodeling and maturation of the lymphatic vasculature, resulting in a profound deficiency of mature collecting lymphatic vessels.
Materials and methods

Mouse colony maintenance and Polymerase Chain Reaction (PCR) genotyping
All animal protocols were approved by the Institutional Animal Care and Use Committee at the University of Arizona (Tucson, AZ). Mice were maintained on the C57BL/6 genetic background and fed a normal 6% fat diet with water ad libitum. Genomic DNA used for genotyping was isolated from tail tips of offspring using a QIAGEN DNeasy blood and tissue kit (catalog number 69506). The PCR reaction to genotype Ang2 mice is as follows: 17.5 µl water; 2.5 µl 10× NH 4 reaction buffer (BIOLINE); 2.0 µl 25 mM MgCl 2 ; 1.0 µl dNTP mix (10 mM of each dNTP; Promega C114H); 1.0 µl primer mix (the mix containing each primer at 0.167 µg/µl); 0.25 µl Taq DNA polymerase (BIOLINE; catalog number BIO-21086); and 1 µl isolated genomic DNA. Primer sequences for the Ang2 PCR are: Ang2 forward 5′-CTT-CTC-TCT-GTG-ACT-GCT-TTG-C-3′; Ang2 reverse 5′-CTG-GGA-TCT-TGT-CTT-GGC-C-3′; and Neo 3′ ds85 5′ GAG-ATC-AGC-AGC-CTC-TGT-TCC-3′. In a BIORAD MyCycler™ thermocycler, the PCR reaction mixture was heated to 95°C for 3 min, and then cycled from 95°C (30 s), to 61°C (30 s), then to 72°C (45 s) 35 times. PCR products of 380 bp (wild-type allele) and 240 bp (mutant allele) were observed after gel electrophoresis and ethidium bromide detection. The PCR reaction to genotype Ang2 A1 mice is as follows: 17.75 µl water; 2.5 µl 10× NH 4 reaction buffer; 1.5 µl 25 mM MgCl 2 ; 1.0 µl dNTP mix; 1.0 µl primer mix (mix containing each primer at 0.167 µg/µl); 0.25 µl Taq DNA polymerase; and 1 µl isolated genomic DNA. The primer sequences for the Ang2 A1 PCR are: JA2/1-F2 5′-GGG-GAG-AAA-CAA-AGA-GTC-CG-3′; Ang1 reverse 5′-GAA-TGG-CAG-CGA-AGA-ATG-C-3′; and Ang2 reverse 5′-CTG-TCC-ACG-CTC-TTC-CTA-AAG-3′. The PCR reaction mixture was heated to 95°C for 3 min, and then cycled from 95°C (30 s), to 55°C (45 s), then to 72°C (45 s) 35 times. A final extension time of 7 min at 72°C followed the last cycle of the reaction. PCR products of 340 bp (wild-type allele) and 280 bp (knock-in allele) were observed after gel electrophoresis and ethidium bromide detection.
Lymphangiography using Evans blue dye
Adult mice were weighed and carefully examined for central and peripheral edema and ascites as well as other gross phenotypic abnormalities. Mice were anesthetized with an intramuscular injection of 20:1:79 (ketamine:xylazine:sterile saline) at approximately 0.1 ml/10 g body weight. Evans blue dye (EBD) (1% w/v) was serially injected intradermally into the hind paws, fore paws, snout, and ear of Ang2 +/+ , Ang2 −/− , and Ang2 A1/A1 mice. Following injections, the popliteal, sacral, iliac, axillary, and jugular regions were dissected and visualized under a dissecting microscope (Weck, Evergreen, CO, USA).
Whole-mount immunofluorescence
We performed whole-mount immunofluorescence analysis of mesentery as well as ear and ventral skin to assess the pattern of the lymphatic system and identify mural cell components of the vasculature. Tissue was fixed with 1% paraformaldehyde for 1 h at room temperature, washed in PBS, permeabilized with 0.3% Triton X-100 in PBS, and then blocked overnight with 3% goat serum in 0.3% Triton X-100 in PBS. Smooth muscle cells were detected by incubating tissues with a Cy3 conjugated anti-α-Smooth Muscle Actin (1:1000; Sigma C-6198) antibody. Initial lymphatic vessels were identified by incubating tissues with a rabbit antibody against LYVE-1 (1:1000; Upstate #07-538) followed by either anti-rabbit Alexa Fluor 488 (1:500; Molecular Probes A11008) or anti-rabbit Alexa Fluor 555 secondary antibodies (1:500; Molecular Probes A21428).
Blood and lymphatic vessels were identified by incubating tissues with a rat antibody against mouse PECAM-1 (1:1000; Cell Sciences HM1013) followed by an anti-rat Alexa Fluor 488 secondary antibody (1:500; Molecular Probes A11006). All incubations took place at 4°C for 24 h. Samples were mounted with Citifluor (Ted Pella Inc., 19470) and analyzed using a fluorescent microscope (Olympus) while images were captured using a Ziess LSM 510 confocal microscope.
Confocal image analysis
For postnatal day 0 and 3 LYVE-1 stained ventral skin whole-mounts, 90 µm thick z stacks were captured using a Ziess LSM 510 confocal microscope. Depth projections and three-dimensional (3D) projections were generated from these z stacks using the LSM Image Browser software package. Following the formation of the 3D projection, images were rotated 90°along the y-axis.
Immunohistochemistry of tissue sections
Ventral skin from postnatal day 0, 3, and 6 pups was isolated, fixed overnight in 4% paraformaldehyde at 4°C, and washed with 70% EtOH. Tissues were then processed, embedded in paraffin, and 5 µm sections were cut for immunohistochemistry. Slides were deparaffinized with Histoclear and rehydrated through a descending alcohol series. Antigen retrieval was performed with a 1× antigen decloaking solution (Biocare Medical; 071207) and heated decloaking chamber (Biocare Medical). After antigen retrieval, slides were washed with PBS and blocked for 1 h with TNB blocking reagent (Perkin Elmer; FP1020) containing 0.1% Triton X-100. Primary antibodies were then added and allowed to incubate for 1 h at room temperature. The following primary antibodies were used: rabbit anti-LYVE-1 (1:200; Upstate #07-538), hamster antipodoplanin (1:500; abcam ab11936) and Cy3 conjugated anti-α-Smooth Muscle Actin (1:1000; Sigma C-6198). After three 5 min washes with PBS + 0.05% Tween 20 (Sigma P-7949), the appropriate secondary antibodies were added and allowed to incubate at room temperature for 1 h. The following secondary antibodies were used: anti-rabbit Alexa Fluor 488 (1:250; Molecular Probes A11008), anti-rabbit Alexa Fluor 555 (1:250; Molecular Probes A21428), and anti-hamster Alexa Fluor 488 (1:250; Molecular Probes A21110). Slides were then washed 3 times for 5 min with PBS + 0.05% Tween 20 and coverslips mounted with Citifluor (Ted Pella Inc., 19470).
Staining for β-galactosidase activity
Ventral skin was isolated from postnatal day 0, 3, and 6, Ang2 +/+ , Ang2 +/− and Ang2 −/− pups then fixed in 0.4% PFA for 15 min. Tissues were washed three times for 15 min with a detergent rinse (2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.02% Nonidet P-40, in PBS-A). Staining solution (2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.02% Nonidet P-40, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and X-gal 1 mg/ml, in PBS-A) was then added to the tissues and they were put at 37°C overnight. S. Samples were mounted and visualized under a microscope (Olympus).
Quantitative analysis
Quantitation of lymphatic valves PECAM-1 stained ears from Ang2 +/+ and Ang2 −/− mice were visualized under a fluorescent microscope. Lymphatic valves were identified by their unique morphology and manually counted per ear. Means (± standard error) were calculated from values of 4 Ang2 +/+ and 4 Ang2 −/− mice. 
Statistical analysis
Unpaired studentTs T-tests were performed to test means for significance.
Results
Ang2
−/− mice on the C57BL/6 genetic background survive to adulthood and exhibit defects of the lymphatic system Ang2 −/− mice on a mixed 129/J and C57BL/6 genetic background were previously reported to die by 2 weeks after birth (Gale et al., 2002) ; however, after continued backcrossing of the Ang2 null mutation onto the C57BL/6 genetic background, we were able to generate Ang2 −/− mice that survived to adulthood. Although Ang2 −/− mice on the C57BL/6 genetic background exhibited increased viability, they retained the grossly abnormal lymphatic phenotypes originally described by Gale et al. (2002) . All Ang2 −/− newborn pups had chylous ascites (Figs. 1A, B) and edematous hind paws, the latter abnormality persisting through adulthood with variable severity (Figs. 1C, D) . Chylothorax was also noted in 25% of adult Ang2 −/− mice at necropsy.
Evans blue dye (EBD) lymphangiography was performed to assess the transport function of lymphatic vessels in the ears of adult Ang2 down-regulated-PECAM-expressing lymphatic vessels were occasionally observed near the base of Ang2 −/− ears.
Closer examination of the PECAM-1 staining also demonstrated that Ang2 −/− mice exhibit a deficiency of collecting lymphatic vessels.
The ordered lymphatic network in the ear skin of Ang2 +/+ mice included initial vessels comprised of oak leaf-shaped endothelial cells (Fig. 4A) , and collecting vessels made up of elongated endothelial cells (Fig. 4B ). Nearly all lymphatic vessels in the ear skin in Ang2 −/− mice were comprised of oak leaf-shaped endothelial cells and lacked a collecting vessel phenotype (Fig. 4C ). Because Ang2 −/− mice exhibit a deficiency of collecting lymphatic vessels, we determined whether they also have a deficit of intraluminal lymphatic valves. Valves were readily identified in the collecting lymphatic vessels of Ang2 +/+ mice by PECAM-1 (Fig. 4D) , and the number of lymphatic valves per ear was dramatically greater in Ang2 +/+ mice (29.75 ± 2.02, n = 4) than Ang2 −/− mice (1.00 ± 0.71, n = 4; P b 0.001; Fig. 4E ). The few valves observed in Ang2 −/− mice exhibited typical characteristics of normal valves (Supplemental Fig. 1 SMCs associate with initial lymphatic vessels of adult Ang2 −/− mice Previous studies have reported that mesenteric lymphatic vessels of Ang2 −/− mice are poorly associated with overlying SMCs whereas initial lymphatic vessels in the digestive organs are extensively covered with SMCs (Gale et al., 2002; Shimoda et al., 2007) . We performed whole-mount immunofluorescence staining of adult ear skin for smooth muscle actin (SMA) and LYVE-1 to determine the effect a deficiency of Ang2 has on the association of SMCs with dermal lymphatic vessels. Initial lymphatic vessels in the skin of Ang2 +/+ mice lacked SMC coverage while mural cells were associated with LYVE-1 downregulated collecting lymphatic vessels (n = 3; Figs. 5A-C). In contrast, SMCs were associated with initial lymphatic vessels in Ang2 −/− mice (n = 5; Figs. 5D-F).
Jugular lymph sacs are normal in embryonic day (E) 12.5 Ang2 −/− embryos
We examined the jugular lymph sacs of E12.5 Ang2 +/+ and Ang2 −/− embryos to determine whether the lymphatic defects exhibited by Ang2 −/− mice were due to abnormal or delayed development of early lymphatic structures. The jugular lymph sacs of E12.5 Ang2 +/+ and Ang2 −/− embryos expressed the lymphatic markers LYVE-1, Prox-1, and podoplanin, and were not surrounded by smooth muscle actin positive cells (Fig. 6A ). These results demonstrate that endothelial cells comprising the lymph sacs in Ang2 −/− mice have properly acquired a lymphatic endothelial cell phenotype. Furthermore, the size of the jugular lymph sacs in E12.5 Ang2 +/+ (74,227 µm 2 ± 17,520.7; n = 3) and Remodeling and maturation of the lymphatic vasculature in the ventral skin of mice has previously been demonstrated to occur between postnatal day 0 and 5 of neonatal development (Mäkinen et al., 2005) . Therefore, we examined the ventral skin of postnatal day 0, 3, and 6 Ang2 +/+ and Ang2 −/− pups to further dissect this fundamental process and to determine whether lymphatic remodeling and maturation was defective in Ang2 −/− pups.
Whole-mount immunofluorescence staining for LYVE-1 demonstrated that lymphatic vessels in the ventral skin of postnatal day 0 Ang2 +/+ pups form a highly connected polygonal plexus (Fig. 7A) . Lymphatic vessels of this primary plexus were similarly colored in depth projections (confocal projections where structures are colored based on depth) indicating that they were in the same tissue plane, and a single plexus of lymphatic vessels was observed after rotating threedimensional (3D) confocal projections 90°(n = 6; Figs. 7B, C). Immunohistochemistry on ventral skin sections demonstrated that all lymphatic vessels of the primary plexus were located between the dermis and subcutaneous tissue (Fig. 7D) . By postnatal day 3, lymphatic vessels in Ang2 +/+ pups had emerged from the primary plexus and begun to form a secondary plexus with numerous sprouts and filopodia (Fig. 7E) . Indeed, lymphatic vessels displayed distinct colors in depth projections indicating that they were in different planes, and two separate plexuses of vessels were observed after rotating 3D confocal projections 90°(n = 4; Figs. 7F, G). Interestingly, the primary plexus did not appear as dense as it did at postnatal day 0 suggesting that lymphatic vessel pruning had occurred. Immunohistochemical staining of ventral skin tissue sections demonstrated that lymphatic vessels of the secondary plexus were located in the dermis while vessels of the deeper primary plexus were located in the subcutaneous tissue (Fig. 7H) . At postnatal day 6, a hierarchal network of initial and collecting lymphatic vessels was present in the skin of Ang2 +/+ pups. The dermis was rich in LYVE-1 positive initial lymphatic vessels whereas subcutaneous lymphatic vessels had matured and down-regulated LYVE-1. Although lymphatic vessels of the primary plexus had down-regulated LYVE-1, they still expressed the lymphatic marker podoplanin (Figs. 7I, J) . Interestingly, lymphatic vessels of Ang2 −/− pups failed to acquire a collecting vessel phenotype during the remodeling phase of lymphatic development. At postnatal day 0, whole-mount immunofluorescence staining for LYVE-1 demonstrated that a primary plexus of lymphatic vessels had formed in Ang2 −/− pups; however, lymphatic vessels appeared abnormal, and the network was hypoplastic (n = 6; Fig. 7L ). Depth projections and 3D projections at this time point showed that only a single plexus was present in the skin (n = 6; Figs. 7M, N), and cross sections of ventral skin demonstrated that all of the lymphatic vessels of this primary plexus were located at the border between the dermis and subcutaneous tissue (n = 3; Fig. 7O ). At postnatal day 3, filopodia were not as prevalent on the lymphatic vessels of Ang2 −/− pups as they were on Ang2 +/+ pups (Fig. 7P) . Furthermore, depth projections and 3D projections demonstrated that only a single plexus of lymphatic vessels was present in the skin of most Ang2 −/− pups (5/6; Figs. 7Q, R). Immunohistochemistry on ventral skin cross sections showed that most lymphatic vessels were located in the subcutaneous primary plexus (Fig. 7S) ; however, a few lymphatic vessels had invaded the dermis and begun to form a secondary plexus (data not shown). At postnatal day 6, lymphatic vessels in the subcutaneous primary plexus of Ang2 −/− pups had not matured and continued to express the initial lymphatic marker LYVE-1 (Figs. 7T, U) . Despite the immaturity of the network, the secondary dermal plexus of initial lymphatic vessels was more developed than at postnatal day 3 but remained hypoplastic. Dermal lymphatic vessels of Ang2 −/− pups prematurely recruit SMCs
To determine if SMCs are recruited to lymphatic vessels in Ang2
−/− mice, before or after the lymphatic remodeling defect occurs, we stained ventral skin sections from postnatal day 0 pups for LYVE-1 and SMA. SMCs were not associated with lymphatic vessels in the skin of postnatal day 0 Ang2 +/+ pups (Figs. 8A-C) . In contrast, SMCs were recruited to 31.5% of lymphatic vessels in the skin of Ang2 −/− pups (Figs. 8D-H ). This observation demonstrates that SMCs associate with lymphatics vessels in Ang2 −/− pups prior to the lymphatic remodeling defect exhibited by these mice.
Lymphatic vessels in the ventral skin of Ang2 −/− pups exhibit β-galactosidase activity during postnatal lymphangiogenic remodeling
The Ang2 null allele (Ang2 − ) was generated by the insertion of the LacZ reporter gene (Gale et al., 2002) , therefore, we stained wholemount ventral skin from pups for β-galactosidase activity to determine whether the Ang2 gene was expressed during lymphangiogenic remodeling. As expected, no β-galactosidase activity was detected in the ventral skin of postnatal day 0, 3, or 6 Ang2 To determine whether initial and collecting lymphatic vessels express the Ang2 receptor, Tie-2, we assessed the pattern of green fluorescence protein (GFP) expression in the ear skin of adult Tie-2-GFP transgenic mice. The lymphatic marker LYVE-1 did not co-localize with GFP, and no lymphatic vessels in the ear skin of Tie-2-GFP transgenic mice expressed GFP; however, GFP expressing blood vessels were readily identified (Supplemental Figs. 3A-C).
Adult Angiopoietin-2 knock-out Angiopoietin-1 knock-in mice (Ang2 A1/A1 ) develop dermal collecting lymphatic vessels and a normally functioning lymphatic vasculature Remarkably, mice that have the first exon of the angiopoietin-2 gene replaced with angiopoietin-1 cDNA (Ang2
) exhibit a wildtype lymphatic phenotype (Gale et al., 2002; Shimoda et al., 2007) . Ang2 A1/A1 mice are grossly indistinguishable from Ang2 +/+ mice, and the patterning of lymphatic vessels in the small intestine as well as other digestive organs has been reported to be normal (Gale et al., 2002; Shimoda et al., 2007) . Because adult Ang2 A1/A1 mice do not appear to display defects of the lymphatic system, we examined the skin of these mice to determine whether lymphatic vessel remodeling and maturation had occurred in these mice. Whole-mount immunofluorescence staining of ear skin for LYVE-1 revealed that the patterning of the dermal lymphatic vasculature of Ang2 A1/A1 mice resembled that of Ang2 +/+ mice more than Ang2 −/− mice (Figs. 10A-C) . LYVE-1 positive initial lymphatic vessels in the peripheral region of ear skin from Ang2 A1/A1 transitioned to LYVE-1 down-regulated PECAM-1 positive collecting lymphatic vessels in the medial region of the ear, demonstrating that lymphangiogenic remodeling and maturation had occurred (n = 3; Figs. 10D-F) . Furthermore, SMCs were associated with LYVE-1 down-regulated collecting lymphatic vessels (n =4; Figs. 10 G-I), except in one region of ear skin of a single mouse where they were found on initial lymphatics. Despite the ability of Ang-1 to qualitatively correct the lymphatic phenotypes of Ang2 −/− mice, the density of lymphatic vessels in the ear skin of Ang2 A1/A1 mice (0.80 ± 0.037, n = 4) was not as high as that of Ang2 +/+ mice (0.90 ± 0.035, n = 4; P b 0.01). Nonetheless, the density of lymphatic vessels in the ear skin of Ang2 A1/A1 mice was substantially higher than that of Ang2 −/− mice (0.65 ± 0.09, n = 4; P b 0.05; Fig. 10J ). Moreover, intradermally injected EBD was effectively transported from the injection site to the base of the ear in all Ang2 A1/A1 mice demonstrating that the hierarchal vasculature was indeed functional (n = 6; Fig. 10K ).
Discussion
Analysis of gene-targeted knock-out and transgenic mice has previously shown that the receptor tyrosine kinase Tie-2 and its ligands, Angiopoietin-1 and -2, are required for the maturation of the primitive blood vasculature (Dumont et al., 1994; Sato et al., 1995; Suri et al., 1996; Maisonpierre et al., 1997; Gale et al., 2002; Hackett et al., 2002) . The present study extends this concept to the lymphatic system demonstrating that Angiopoietin-2 is also required for the transformation of the primitive lymphatic vasculature into a hierarchal network of initial and collecting vessels.
Whole-mount immunofluorescence results show that lymphatic vessels in Ang2 −/− mice fail to mature and do not exhibit a collecting vessel phenotype. It has previously been demonstrated that lymphatic vessels normally mature and acquire a collecting vessel phenotype during lymphangiogenic remodeling (Sabin 1904; Heuer 1909; Mäkinen et al., 2005) . Therefore, we examined this process in detail to determine whether it was altered in Ang2 −/− mice. In Ang2 +/+ pups, lymphatic sprouts emerge from a primary plexus of lymphatic vessels to form a secondary plexus of initial lymphatic vessels. Subsequently, vessels in the primary plexus down-regulate LYVE-1 and exhibit a collecting vessel phenotype (Fig. 11) . In Ang2
pups, a dysplastic primary plexus of vessels forms which has prematurely recruited SMCs. Only a few sprouts emerge from the primary plexus to form a hypoplastic secondary plexus of initial lymphatic vessels. Later in development, lymphatic vessels of the primary plexus fail to down-regulate LYVE-1 expression, and an immature phenotype persists (Fig. 11 ). These observations demonstrate that Ang-2 is required for the postnatal remodeling and maturation of the lymphatic vasculature as well as the postnatal remodeling of the blood vasculature. Members of the vascular endothelial growth factor and Angiopoietin families are thought to function in a complementary fashion during the development and subsequent remodeling of the blood vasculature. VEGF-A is required for initial development of the blood vasculature (hemevasculogenesis and hemangiogenesis), whereas, Angiopoietin-1 (Ang-1) is thought to function as a stabilizing factor and promote the association of mural cells with nascent blood vessels (Suri et al., 1996) . Mural cells presumably protect blood vessels from regression and are thought to stabilize the vascular network by inducing the quiescence of endothelial cells through the activation of factors such as TGF-β (Orlidge and D'Amore, 1987; Antonelli-Orlidge et al., 1989; Hellström et al., 2001; von Tell et al., 2006) . Conversely, Ang-2 is thought to destabilize blood vessels during hemangiogenic remodeling, and, in the absence of VEGF-A, cause blood vessel regression, whereas in the presence of VEGF-A, facilitate hemangiogenesis (Maisonpierre et al., 1997; Holash et al., 1999; Lobov et al., 2002; Visconti et al., 2002) . Defective remodeling of the blood and lymphatic vasculatures in mice lacking Ang-2 raises the possibility that Ang-2 serves similar functions in hemangiogenic and lymphangiogenic remodeling. Furthermore, Ang-2 may work in a complementary fashion with a member (or members) of the vascular endothelial growth factor family during lymphangiogenic remodeling. Reports on vascular endothelial growth factor-C (Vegfc) deficient mice and Chy-3 mice (Vegfc hemizygotes) have demonstrated that Vegfc is required for lymphvasculogenesis and lymphangiogenesis during embryonic development (Karkkainen et al., 2004; Dellinger et al., 2007) . During embryonic and postnatal lymphatic development, Ang-2 would maintain lymphatic vessel plasticity by preventing the association with mural cells and thereby facilitate lymphangiogenesis in the presence of VEGF-C. Lack of Ang2, on the other hand, causes the premature recruitment of SMCs to lymphatic vessels. These mural cells could release factors that prematurely stabilize the lymphatic vasculature leading to lymphatic hypoplasia and failure in the transformation of primitive lymphatic vessels into collecting lymphatic vessels.
The association of SMCs with initial lymphatic vessels in the skin of Ang2 −/− mice suggests that Ang2 maybe required to prevent SMCs from interacting with lymphatic vessels. Further evidence also implicates Ang2 in destabilizing the association of mural cells with endothelial cells. Ang2 is associated with the loss of pericytes from blood vessels surrounding tumors (Zhang et al., 2003) , induces pericyte dropout of the retinal vasculature (Hammes et al., 2004; Feng et al., 2007) , and destabilizes the interaction between endothelial cells and smooth muscle cells in a three-dimensional co-culture system (Scharpfenecker et al., 2005) . Furthermore, cells expressing pericyte markers excessively surround cortical peritubular blood capillaries in the kidneys of Ang2
mice (Pitera et al., 2004) . Despite these observations, the mechanism whereby Ang2 inhibits or disrupts mural cell association with endothelial cells remains unclear. Recently, initial lymphatic vessels in mouse embryos deficient in the transcription factor Foxc2 have been shown to be covered with SMCs, and collecting lymphatic vessels do not exhibit intraluminal valves . Foxc2 has been proposed to inhibit SMC coverage of initial lymphatic vessels by repressing the expression of platelet-derived growth factor B (Pdgf-b), a gene essential for the recruitment of pericytes to blood capillaries (Lindahl et al., 1997; Petrova et al., 2004 shown to express Ang2 mRNA (Maisonpierre et al., 1997) . Surprisingly, β-galactosidase activity was detected in lymphatic vessels when two copies of the LacZ gene were present (Ang2
). This observation suggests that either 1) Ang2 is weakly expressed by lymphatic endothelial cells and two copies of the reporter gene are required for detection, or, alternatively, 2) Ang2 protein negatively regulates Ang2 gene expression in lymphatic endothelial cells. Ang2 protein has been shown to negatively regulate Ang2 mRNA levels in bovine mesenteric endothelial cells as well as HUVECs, and a negative feedback loop has been proposed to tightly regulate the expression of the Ang2 gene (Mandriota and Pepper 1998; Daly et al., 2006) . In Ang2 +/− pups, Ang2 may be expressed during early development, and the protein stored in Weibel-Palade bodies (Fiedler et al., 2004) . Ang2 protein could be released during lymphangiogenic remodeling and inhibit the expression of the LacZ reporter gene by lymphatic endothelial cells. In contrast, no Ang2 protein is present in Ang2 −/− mice to inhibit the Ang2 promoter, therefore, transcription from the Ang2 promoter could persist. β-galactosidase activity would then be detected in lymphatic endothelial cells at later stages of development. Further experiments are necessary to distinguish between these two alternative models.
In addition to Ang2, we also assessed the expression of GFP in adult Tie-2-GFP transgenic mice to determine whether the Ang2 receptor, Tie-2, was differentially expressed by initial and collecting lymphatic vessels. Neither initial nor collecting lymphatic vessels in the ear skin of Tie-2-GFP transgenic mice expressed GFP suggesting that mature lymphatic vessels do not express Tie-2. However, LYVE-1 positive lymphatic vessels have previously been shown to express Tie-2 by immunofluorescence staining of mouse ear skin and small intestine using an antibody against Tie-2 ( Morisada et al., 2005; Tammela et al., 2005) . The discrepancy between the results obtained from Tie-2 -GFP transgenic mice and immunohistochemistry for the Tie-2 protein may be because regulatory elements controlling the expression of Tie-2 by lymphatic vessels are not included in the Tie-2-GFP transgenic construct. Further delineation of the expression pattern of Tie-2 by immunohistochemistry may better define the role of Tie-2 in the development and maintenance of the lymphatic vasculature. Interestingly, Tie-1, a related receptor capable of forming heterodimers with Tie-2, is expressed by initial and collecting lymphatic vessels in adult mice raising the possibility that it serves a function in the development or maintenance of the lymphatic vasculature (Iljin et al., 2002; Saharinen et al., 2005) .
Lastly, we demonstrated that dermal lymphatic vessels of Ang2
mice exhibit a normal pattern and function. Angiopoietin-1 has previously been demonstrated to be pro-lymphangiogenic and to rescue the abnormal lymphatic phenotype of Ang2 knock-out mice (Gale et al., 2002 Tammela et al., 2005; Kim et al., 2007; Shimoda et al., 2007) . These observations suggest that activation of Tie-2 induces lymphangiogenesis and is crucial for normal lymphatic development. Indeed, Ang2 induces the autophosphorylation of Tie-2 expressed by cultured bovine mesenteric lymphatic endothelial cells (Nguyen et al., 2007) . Despite the qualitative and functional rescue of the lymphatic phenotype of Ang2 −/− mice by Ang1, the dermal lymphatic vasculature of Ang2 A1/A1 mice is slightly hypoplastic compared to Ang2 +/+ mice. Ang2 has recently been shown to be more effective than Ang-1 in inducing the proliferation and survival of bovine mesenteric lymphatic endothelial cells, which could explain why the lymphatic vessel density in the skin of Ang2 A1/A1 mice is not quite as high as that of Ang2 +/+ mice (Nguyen et al., 2007) . Failure of lymphatic vessel maturation in Ang2 −/− mice leads to ineffective fluid transport by lymphatic vessels resulting in lymphedema. Furthermore, the dysfunctional and potentially obstructed lymphatic vessels could be the underlying cause of chylous ascites in Ang2 −/− mice. Recently, it has been demonstrated that tight junction proteins exhibit a discontinuous distribution along the cell-cell interface of endothelial cells comprising initial lymphatic vessels whereas endothelial cells of collecting lymphatic vessels show a continuous distribution of tight junction proteins along the cell-cell interface Tammela et al., 2007) . Because mesenteric lymphatic vessels in Ang2 −/− mice fail to mature, lymphatic endothelial cells comprising these vessels may not have a continuous distribution of tight junction proteins around their interfaces and therefore, exhibit enhanced permeability leading to chylous ascites. Taken together, these results demonstrate that Ang-2 is required for the remodeling and maturation of the lymphatic vasculature. These findings further delineate the process of lymphatic remodeling and could provide translational clues relevant to the pathogenesis and treatment of clinical disorders of the lymphatic system.
